ABC | Volume 110, Nº6, June 2018

Original Article Marui et al Blood pressure variables in Duchenne muscular dystrophy Arq Bras Cardiol. 2018; 110(6):551-557 1. Emery AE. Population frequencies of inherited neuromuscular diseases—a world survey. Neuromuscul Disord. 1991;1(1):19-29. 2. McDonald CM. Physical activity, health impairments, and disability in neuromusculardisease.Am JPhysMedRehabil.2002;81(11Suppl):108-20. 3. Childers MK, Okamura CS, Bogan DJ, Bogan JR, Sullivan MJ, Kornegay JN. Myofiber. Injury and regeneration in a canine homologue of Duchenne muscular dystrophy. Am J Phys Med Rehabil. 2001;80(3):175-81. 4. Kueh SL, Head SI, Morley JW. GABA(A) receptor expression and inhibitory post-synaptic currents in cerebellar Purkinje cells in dystrophin-deficient mdx mice. Clin Exp Pharmacol Physiol. 2008;35(2):207-10. 5. Nigro G, Comi LI, Politano L, Bain RJ. The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol. 1990;26(3):271-7. 6. Connuck DM, Sleeper LA, Colan SD, Cox GF, Towbin JA, Lowe AM, et al; Pediatric Cardiomyopathy Registry Study Group. Characteristics and outcomesofcardiomyopathy inchildrenwithDuchenneorBeckermuscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry. AmHeart J. 2008;155(6):998-1005. 7. Cox GF, Kunkel LM. Dystrophies and heart disease. Curr Opin Cardiol. 1997;12(3):329-43. 8. Feng J, Schaus BJ, Fallavollita JA, Lee TC, Canty JM Jr. Preload induces troponin I degradation independently of myocardial ischemia. Circulation 2001;103(16):2035-7. 9. Woolf PJ, Lu S, Cornford-Nairn R, Watson M, Xiao XH, Holroyd SM, et al. Alterations in dihydropyridine receptors in dystrophin-deficient cardiac muscle. Am J Physiol Heart Circ Physiol. 2006;290(6):H2439-45. 10. Williams IA, AllenDG. Intracellular calciumhandling in ventricular myocytes frommdx mice. Am J Physiol Heart Circ Physiol. 2007; 292(2):H846-55. 11. AmericanAcademyofPediatrics,SectiononCardiologyandCardiacSurgery. Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy. Pediatrics. 2005;116(6):1569-73. 12. Viollet L, Thrush PT, Flanigan KM, Mendell JR, Allen HD. Effects of angiotensin-converting enzyme inhibitors and/or beta blockers on the cardiomyopathy in Duchenne muscular dystrophy. Am J Cardiol. 2012;110(1):98-102. 13. SociedadeBrasileiradeCardiologia.VDiretrizesBrasileirasdeMonitorização Ambulatorial da Pressão Arterial (MAPA) e III Diretrizes Brasileiras de Monitorização Residencial da Pressão Arterial (MRPA). Rev Bras Hipertens. 2011;18(1):18-25. 14. Urbina E, Alpert B, Flynn J, Hayman L, Harshfield GA, Jacobson M, et al. American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee. Ambulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the council on cardiovascular disease in the young and the council for high blood pressure research. Hypertension. 2008;52(3):433-51. 15. Flynn JT, Daniels SR, Hayman LL, Maahs DM, McCrindle BW, Mitsnefes M, etal;AmericanHeartAssociationAtherosclerosis,HypertensionandObesity in Youth Committee of the Council on Cardiovascular Disease in the Young. Update: ambulatory blood pressuremonitoring in children and adolescents: a scientific statement from the AmericanHeart Association Atherosclerosis, Hypertension and Obesity in Youth Committee of the Council on Cardiovascular Disease in the Young. Hypertension. 2014;63(5):1116-35. 16. Varda NM, Gregoric A. Twenty-four-hour ambulatory blood pressure monitoring in infants and toddlers. Pediatr Nephrol. 2005;20(6):798-802. 17. Manzur AY, Kinali M, Muntoni F. Update on the management of Duchenne muscular dystrophy. Arch Dis Child. 2008;93(11):986-90. 18. Manzur AY, Kuntzer T, Pike M, Swan AV. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst Rev. 2008;23(1):CD003725. 19. Braat E, Hoste L, De Waele L, Gheysens O, Vermeersch P, Goffin K, et al. Renal function in children and adolescents with Duchenne muscular dystrophy. Neuromuscul Disord. 2015;25(5):381-7. 20. AmericanAcademyofPediatrics,SectiononCardiologyandCardiacSurgery. Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy. Pediatrics. 2005;116(6):1569-73. 21. National High Blood Pressure Education ProgramWorking Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(2 Suppl 4th Report):555-76. 22. O’Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, et al. European SocietyofHypertensionWorkingGrouponBloodPressureMonitoring.Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressuremeasurement. J Hypertens. 2005;23(4):697-701. 23. Masood SA, Kazmouz S, Heydemann P, Li H, Kenny D. Under-recognition of Low Blood Pressure Readings in Patients with Duchenne Muscular Dystrophy. Pediatr Cardiol. 2015;36(7)1489-94. 24. Malachias MV, Souza WK, Plavnik FL, Rodrigues CI, Brandão AA, Neves MF, et al; Sociedade Brasileira de Cardiologia. 7a Diretriz Brasileira de hipertensão arterial. Arq Bras Cardiol. 2016;107(3 supl 3):1-83. 25. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al; DMDCare Considerations Working Group. Diagnosis and management of Duchennemuscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol. 2010;9(2):177-89. 26. Loufrani L, Levy BI, Henrion D. Defect in microvascular adaptation to chronic changes in blood flow in mice lacking the gene encoding for dystrophin. Circ Res. 2002;91(12):1183-9. 27. Thomas GD, Sander M, Lau KS, Huang PL, Stull JT, Victor RG. Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. Proc Natl Acad Sci USA. 1998;95(25):15090-5. 28. Thomas GD, Shaul PW, Yuhanna IS, Froehner SC, Adams ME. Vasomodulation by skeletal muscle-derived nitric oxide requires alpha- syntrophin-mediated sarcolemmal localization of neuronal Nitric oxide synthase. Circ Res. 2003;92(5):554-60. 29. Brenman JE, Chao DS, Xia H, Aldape K, Bredt DS. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 1995;82(5):743-52. 30. ChangWJ, Iannaccone ST, Lau KS, Masters BS, McCabe TJ, McMillan K, et al. Neuronalnitricoxidesynthaseanddystrophin-deficientmusculardystrophy. Proc Natl Acad Sci USA. 1996;93(17):9142-7. References 556